Literature DB >> 8603024

Heparin-induced skin lesions.

T E Warkentin1.   

Abstract

Six patients who developed heparin-induced skin lesions were tested for the presence of heparin-dependent, platelet-activating IgG irrespective of whether they developed thrombocytopenia. All six patients' sera contained potent heparin-dependent, platelet-activating IgG. However, only two of the six patients developed thrombocytopenia, and both of these patients developed thrombotic complications. One of the four patients who developed skin lesions without thrombocytopenia also developed a characteristic complication of heparin-induced thrombocytopenia (adrenal haemorrhagic infarction). These observations indicate that formation of heparin-dependent, platelet-activating IgG is a consistent feature of patients who developed heparin-induced skin lesions irrespective of whether thrombocytopenia occurs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603024     DOI: 10.1046/j.1365-2141.1996.d01-1481.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

Review 1.  Heparin-induced thrombocytopenia: patient profiles and clinical manifestations.

Authors:  F A Spencer
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

2.  Images in heparin-induced thrombocytopenia.

Authors:  O Ali
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

3.  Skin necrosis in patients with arterial catheters flushed with a solution containing heparin.

Authors:  Henry Thomas Stelfox; Barry Kushner
Journal:  Intensive Care Med       Date:  2012-02-23       Impact factor: 17.440

Review 4.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Thrombocytopenias: a clinical point of view.

Authors:  Dino Veneri; Massimo Franchini; Federica Randon; Ilaria Nichele; Giovanni Pizzolo; Achille Ambrosetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

Review 6.  Heparin-induced thrombocytopenia and thrombosis.

Authors:  G Arepally; D B Cines
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

7.  Over-testing for heparin induced thrombocytopenia in hospitalized patients.

Authors:  Shruti Chaturvedi; Ruhail Kohli; Keith McCrae
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

8.  4Ts scoring with hemofiltration or hemodialysis clotting.

Authors:  Theodore E Warkentin
Journal:  J Clin Monit Comput       Date:  2015-02       Impact factor: 2.502

Review 9.  Heparin-induced skin necrosis and low molecular weight heparins.

Authors:  P J Drew; M J Smith; M A Milling
Journal:  Ann R Coll Surg Engl       Date:  1999-07       Impact factor: 1.891

Review 10.  Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.

Authors:  R Wütschert; P Piletta; H Bounameaux
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.